Cargando…
The M6A methyltransferase METTL3 promotes the development and progression of prostate carcinoma via mediating MYC methylation
N6-methyladenosine (m(6)A) is the richest modification in mammalian messenger RNAs (mRNAs), and exerts key roles in many biological processes, including cancer development, whereas its roles in prostate carcinoma (PCa) remain to be unclear. Here, we found that m(6)A modifications are increased in PC...
Autores principales: | Yuan, Yan, Du, Yang, Wang, Lei, Liu, Xiuheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150444/ https://www.ncbi.nlm.nih.gov/pubmed/32284755 http://dx.doi.org/10.7150/jca.42338 |
Ejemplares similares
-
m(6)A Methyltransferase METTL3 Promotes the Progression of Primary Acral Melanoma via Mediating TXNDC5 Methylation
por: Yue, Zhanghui, et al.
Publicado: (2022) -
Progression of Thyroid Carcinoma Is Promoted by the m6A Methyltransferase METTL3 Through Regulating m(6)A Methylation on TCF1
por: Wang, Kejin, et al.
Publicado: (2020) -
HBXIP promotes gastric cancer via METTL3-mediated MYC mRNA m6A modification
por: Yang, Zhi, et al.
Publicado: (2020) -
m(6)A methyltransferase METTL3 promotes retinoblastoma progression via PI3K/AKT/mTOR pathway
por: Zhang, Han, et al.
Publicado: (2020) -
METTL3 Promotes the Progression of Gastric Cancer via Targeting the MYC Pathway
por: Yang, Dong-Dong, et al.
Publicado: (2020)